Norbert Galldiks, Professor for Neurology at University Hospital Cologne, shared an article on X:
“Happy to share our latest work.
Our initial results suggest the potential of amino acid PET using FET for identifying metabolic responders to vorasidenib in IDH-mutant gliomas.”
Evaluation of early metabolic changes following vorasidenib using FET PET in patients with IDH-mutant gliomas.
Authors: Norbert Galldiks, et al.
